Work

Rationale for combination use of targeted agents in ovarian cancer

Year: 2008

Type: article

Abstract: Current advances in targeted agents for the treatment of ovarian cancer stand on scores of negative clinical studies in tumor types with similar target expression, promising in vitro and in vivo preclinical data, and acceptable safety profiles in their early clinical development. The expanding menu of effective compounds challenges investigators and treating physicians to develop an appropriate rationale for developing novel regimens.

Source: Cancer

DOI: 10.1002/cncr.23604

Authors: Robert L. Coleman, Elise C. Kohn

Institutions: The University of Texas MD Anderson Cancer Center, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W1964810959

FWCI: 1.158

Cites: 18

Cited by: 3

Related to: 10